He, Weiying
Li, Huiyu
Sun, Wenjia
Zhang, Yanggeling
Wu, De
Ao, Chunxia
Wang, Jincheng
Yang, Yanan
Xiao, Xuexue
Zhang, Luyao
Yue, Junqiu
Wang, Xiyuan
Funding for this research was provided by:
Wu Jieping Medical Foundation
Jiangsu Simcere Pharmaceutical Co., Ltd.
Article History
Received: 16 January 2025
Accepted: 25 May 2025
First Online: 9 June 2025
Declarations
:
: This is to certify that the design and methods of the research are in accordance with the requirements of related regulations and procedures (such as GCP and ICH–GCP) as well as the ethical principles. This study was approved by the Institutional Review Board of the Hubei Cancer Hospital (LCKY2024005).
: All the participants provided written informed consent.
: XY. W, HY. L, CX. A and JC. W were employees of SimcereZaiming Pharmaceutical Co., Ltd. at the time of day. Other authors declare no competing financial interest.